Newfound Research’s Idexx Laboratories IDXX Stock Holding History

Newfound Research’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$78K	Buy	238 +1	+0.4%	+$367	0.19%	57
2022 Q2	$83K	Sell	237 -22	-8%	-$8.97K	0.18%	77
2022 Q1	$142K	Buy	259 +145	+127%	+$76.3K	0.18%	48
2021 Q4	$75K	Buy	114 +18	+19%	+$11.3K	0.09%	113
2021 Q3	$60K	Buy	96 +22	+30%	+$14.8K	0.1%	110
2021 Q2	$47K	Buy	+74	New	+$40.9K	0.09%	106
2021 Q1	–	Sell	-240	Closed	-$120K	–	140
2020 Q4	$120K	Buy	240 +144	+150%	+$64.4K	0.31%	55
2020 Q3	$38K	Buy	+96	New	+$35.5K	0.11%	41

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Newfound Research's IDXX Position: Q3 2022 in Review

Newfound Research increased its Idexx Laboratories (IDXX) stake by 0.42% in Q3 2022, buying an estimated $367 and bringing the position to 238 shares worth $78K. The position accounts for 0.19% of the portfolio, ranked #57.

Newfound Research first reported a position in IDXX in Q3 2020 and has held it in 8 quarters since. The position peaked at $142K in Q1 2022. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

Newfound Research held 238 shares of Idexx Laboratories worth $78K as of Q3 2022.
Newfound Research bought 1 Idexx Laboratories share in Q3 2022, an estimated $367.
Idexx Laboratories made up 0.19% of Newfound Research's portfolio in Q3 2022, its #57 holding.
Newfound Research first reported a position in Idexx Laboratories in Q3 2020 and has held it in 8 quarters since.
Newfound Research's Idexx Laboratories position peaked at $142K in Q1 2022.
924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.